drugset / Trial / NCT00712712
Morphine After Radiofrequency Ablation of Painful Bone Metastases in Patients With Cancer
NaSingle-groupOpen-labelSupportive care
Summary
RATIONALE: Morphine may reduce pain in patients who have undergone radiofrequency ablation to remove bone metastases. PURPOSE: This phase II trial is studying how well morphine works after radiofrequency ablation of painful bone metastases in patients with cancer.
Timeline
- Start
- 2007-12-24
- Primary completion
- 2016-02-11
- Completion
- 2016-03-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Morphine | Other / unclassified | — | — |
| Background | Acetaminophen | Small molecule | 4 g | Intravenous |